| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 13
| Issue : 1 | Page : 35 |
|
|
Prevalence of nonalcoholic fatty liver disease in children with renal failure underwent treatment with dialysis
Yahya Madihi1, Reza Tavakoli2, Maryam Riahinezhad3, Neda Mostofizadeh4, Mehryar Mehrkash1, Noushin Rostampour4, Silva Hovsepian5
1 Department of Pediatric Nephrology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Radiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4 Metabolic Liver Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
5 Metabolic Liver Diseases Research Center, Isfahan University of Medical Sciences; Imam Hossein Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Correspondence Address:
Neda Mostofizadeh
Metabolic Liver Diseases Research Center, Isfahan University of Medical Sciences, Isfahan
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijpvm.ijpvm_410_21
|
|
|
Background: In this study, we aimed to investigate the prevalence of nonalcoholic fatty liver disease (NAFLD) in children with renal failure under treatment with dialysis and its association with biochemical measurements. Methods: In this cross-sectional study, children aged less than 18 years with chronic kidney disease (CKD) who were under treatment with dialysis at least 3 months ago were enrolled. To evaluate fatty liver in those patients who had no recent liver ultrasonography (last 6 months), liver ultrasonography was performed. The characteristics of patients with renal failure with and without NAFLD based on the ultrasonographic evaluation were compared. The association between NAFLD and the studied variables was evaluated. Results: In this study, 39 children (31 males and 8 females) with renal failure who underwent treatment with dialysis were included. From the studied population, six (19.4%) had NAFLD based on ultrasonographic evaluation. There were no differences between renal failure patients with and without NAFLD regarding the biochemical and anthropometric characteristics (P > 0.0). Conclusions: The prevalence of NAFLD in our studied children with renal failure who underwent treatment with dialysis was like the general population and it was not associated with the biochemical and anthropometric characteristics of the patients. Given the importance of NAFLD in renal failure patients as well as its subtle nature, it is recommended to screen patients with CKD for NAFLD.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
